| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6070295 | Journal of the American Academy of Dermatology | 2015 | 10 Pages |
Abstract
Baseline tuberculosis testing remains the only screening test with strong evidence to support its practice. Other screening and monitoring tests commonly performed in patients who are taking biologic agents are supported only in certain clinical settings or lack evidence to support or recommend against their practice.
Keywords
CMPHBsAbHBcAbLFTUSPSTFIGRAHBsAgAdalimumabCBCTSTChFNMSCALTTNFAADustekinumabtuberculin skin testingdsDNAPSAFDAdouble-stranded DNApsoriatic arthritisLiver function testASTalanine transaminaseALPAlkaline phosphataseantinuclear antibodyHepatitis B surface antigenAmerican Academy of DermatologyetanerceptUS Food and Drug AdministrationANASafetyInfliximabBADDirect bilirubinBiologicsaspartate transaminaseInterferon-gamma release assaynonmelanoma skin cancerhepatitis B surface antibodycomplete blood cell countScreeningtumor necrosis factorBMPcongestive heart failureMonitoringhepatitis B core antibodyHBVHepatitis C virusHCVhuman immunodeficiency virusHIVhepatitis B virusC-reactive proteinCRPPsoriasistotal bilirubin
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Christine S. MD, Emily H. BA, Michael L. BA, Steven R. MD, PhD, William W. MD, MPH,